| Gene Symbol | LINJ_29_1820 |
| Entrez Gene ID | 5070734 |
| Full Name | conserved hypothetical protein |
| Gene Type | protein-coding |
| Organism | Leishmania infantum JPCM5 |
- REAGENT SERVICES Hot!
-
PRODUCTS
-
Most Popular Reagents
-
Instruments
-
Antibodies
-
ELISA Kits
-
Protein Electrophoresis and Blotting
-
Protein and Antibody Purification
-
Recombinant Proteins
-
Molecular Biology
-
Stable Cell Lines
-
Cell Isolation and Activation
-
IVD Raw Materials
-
Therapy Applications
-
Resources
-
![AmMag™ Quatro Automated Plasmid Purification]()
AmMag™ Quatro automated plasmid purification
-
![Anti-Camelid VHH]()
MonoRab™ Anti-VHH Antibodies
-
![ELISA Kits]()
ELISA Kits
-
![Precast Gels]()
SurePAGE™ Precast Gels
-
![Quatro ProAb Automated Protein and Antibody Purification System]()
AmMag™ Quatro ProAb Automated Protein and Antibody Purification System
-
![Target Proteins]()
Target Proteins
-
![AmMag™ Quatro Automated Plasmid Purification]()
AmMag™ Quatro automated plasmid purification
-
![Stable Cell Lines]()
Stable Cell Lines
-
![Cell Isolation and Activation]()
Cell Isolation and Activation
-
![Quick
Order]()
Quick Order
-
![Quick
Order]()
Quick Order
- APPLICATIONS
- RESOURCES
- ABOUT US
LINJ_29_1820 cDNA ORF clone, Leishmania infantum JPCM5
-
Gene
-
Clones
gRNAs
The following LINJ_29_1820 gene cDNA ORF clone sequences were retrieved from the NCBI Reference Sequence Database (RefSeq). These sequences represent the protein coding region of the LINJ_29_1820 cDNA ORF which is encoded by the open reading frame (ORF) sequence. ORF sequences can be delivered in our standard vector, pcDNA3.1+/C-(K)DYK or the vector of your choice as an expression/transfection-ready ORF clone. Not the clone you want? Click here to find your clone.
-
Reference Sequences (Refseq)
CloneID OLc04270 Clone ID Related Accession (Same CDS sequence) XM_001466661.1 Accession Version XM_001466661.1 Latest version! Documents for ORF clone product in default vector Sequence Information ORF Nucleotide Sequence (Length: 1062bp)
Protein sequence
SNPVector pcDNA3.1-C-(k)DYK or customized vector 
User ManualClone information Clone Map MSDSTag on pcDNA3.1+/C-(K)DYK C terminal DYKDDDDK tags ORF Insert Method CloneEZ™ Seamless cloning technology Insert Structure linear Update Date 1436889600000 Organism Leishmania infantum JPCM5 Product conserved hypothetical protein Comment Comment: PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. This record is derived from an annotated genomic sequence (NC_009413). COMPLETENESS: incomplete on both ends.
1
61
121
181
241
301
361
421
481
541
601
661
721
781
841
901
961
1021ATGATGGACC CCATCCATGT GAGCTGGACC GACATCGCCG GCTCCGACAC CACACCAGGG
GCACGCCTGG CCGCTGGCCG CGTGCTGTCG ATGCTCGACA TGTGCGCCGC CCGCACCTCT
CAGAAGGCGG TTGACCATCA GGCCTGTCTG ACTCATGAGC GGTACCTGAC CTGCACCGTG
GGCGTCACGG ACACAATTTT CTCGTCGCCC ATCCTGCACG GTGACGCGGT CCGTCTAGAC
AGCCGCCTGG TACACTGTGG CTCCAGCTCT ATGGGCATTT ACATTCGGTT TTACCGGCAG
TCGCCGTCGA CCCGCACCGA GACGCCGGCT GGCCATTCCT TCTTCACCAT GGTGGCCATC
ACGCCAGATT TGAAGGCGGC CAAGGTGGTG CCAGCGATAG AGCTGACGGA CCCGTTTGAC
ATTGAACTGC ATAACCACTA TGTGAAAGTT CGCAAGCTTC AGGAGGAAAA CAAGAAGAAC
ACGGCCGAGC GCTTGAAGCG CACCCTCACC ACGGAGGAGG TGCAGTGCTC CATCAACCAG
CAGAAGCCCA CTCATGCCCG TATCAACTCC ACCAAGGTGG AGGCGAACCG CATCTTCTTC
ACATCCTGCA TGAACAACAA CAACACCGTC TTTGGCGGAG AGCTGATGGC GTGGATGGAG
CAGCACGCCG TTCATTGCGG CCGCACGTTC ACCGCCAACC GCCATGTCTT TACGATTGGA
ATGCACAGTG TTGCCTTCCC CGAGCCGGTG TTCGCCACGG ACTGGGTGAC GCTCGAGGCG
ACCGTCATAT ATGTGCGCAA CACCACAATG GAGGTGGATG TGGTGCTCAA GGCGGAGCGC
AAAGACACCA GCACCGTCAT CACGAATCGT GCGTCCTTTG TGTTGATCAA TAACGATGAT
ATTGGGCGGA AATGCACCAT CCCGGTCGGG CTGGAGCTGA ATGGGGCGAC GCAGGAGGAA
CTCCAGCAGT TCATGGAGGC CCGTGTACGA TACCGCTGCA GCGTGGCCCG TCGTGACGAC
CTCCATGCCA GCAACCTTTG TACAGGCATG ACGAAGCTGT AGThe stop codons will be deleted if pcDNA3.1+/C-(K)DYK vector is selected.
RefSeq XP_001466698.1 CDS 1..1062 Translation 
Target ORF information:
RefSeq Version XM_001466661.1 Organism Leishmania infantum JPCM5 Definition Leishmania infantum JPCM5 conserved hypothetical protein partial mRNA. Target ORF information:
Epitope DYKDDDDK Bacterial selection AMPR Mammalian selection NeoR Vector pcDNA3.1+/C-(K)DYK 
XM_001466661.1
ORF Insert Sequence:
1
61
121
181
241
301
361
421
481
541
601
661
721
781
841
901
961
1021ATGATGGACC CCATCCATGT GAGCTGGACC GACATCGCCG GCTCCGACAC CACACCAGGG
GCACGCCTGG CCGCTGGCCG CGTGCTGTCG ATGCTCGACA TGTGCGCCGC CCGCACCTCT
CAGAAGGCGG TTGACCATCA GGCCTGTCTG ACTCATGAGC GGTACCTGAC CTGCACCGTG
GGCGTCACGG ACACAATTTT CTCGTCGCCC ATCCTGCACG GTGACGCGGT CCGTCTAGAC
AGCCGCCTGG TACACTGTGG CTCCAGCTCT ATGGGCATTT ACATTCGGTT TTACCGGCAG
TCGCCGTCGA CCCGCACCGA GACGCCGGCT GGCCATTCCT TCTTCACCAT GGTGGCCATC
ACGCCAGATT TGAAGGCGGC CAAGGTGGTG CCAGCGATAG AGCTGACGGA CCCGTTTGAC
ATTGAACTGC ATAACCACTA TGTGAAAGTT CGCAAGCTTC AGGAGGAAAA CAAGAAGAAC
ACGGCCGAGC GCTTGAAGCG CACCCTCACC ACGGAGGAGG TGCAGTGCTC CATCAACCAG
CAGAAGCCCA CTCATGCCCG TATCAACTCC ACCAAGGTGG AGGCGAACCG CATCTTCTTC
ACATCCTGCA TGAACAACAA CAACACCGTC TTTGGCGGAG AGCTGATGGC GTGGATGGAG
CAGCACGCCG TTCATTGCGG CCGCACGTTC ACCGCCAACC GCCATGTCTT TACGATTGGA
ATGCACAGTG TTGCCTTCCC CGAGCCGGTG TTCGCCACGG ACTGGGTGAC GCTCGAGGCG
ACCGTCATAT ATGTGCGCAA CACCACAATG GAGGTGGATG TGGTGCTCAA GGCGGAGCGC
AAAGACACCA GCACCGTCAT CACGAATCGT GCGTCCTTTG TGTTGATCAA TAACGATGAT
ATTGGGCGGA AATGCACCAT CCCGGTCGGG CTGGAGCTGA ATGGGGCGAC GCAGGAGGAA
CTCCAGCAGT TCATGGAGGC CCGTGTACGA TACCGCTGCA GCGTGGCCCG TCGTGACGAC
CTCCATGCCA GCAACCTTTG TACAGGCATG ACGAAGCTGT AGThe stop codons will be deleted if pcDNA3.1+/C-(K)DYK vector is selected.
-
PubMed
Chromosome and gene copy number variation allow major structural change between species and strains of Leishmania.
Genome research21(12)2129-42(2011 Dec)
Rogers MB,Hilley JD,Dickens NJ,Wilkes J,Bates PA,Depledge DP,Harris D,Her Y,Herzyk P,Imamura H,Otto TD,Sanders M,Seeger K,Dujardin JC,Berriman M,Smith DF,Hertz-Fowler C,Mottram JC
Comparative genomic analysis of three Leishmania species that cause diverse human disease.
Nature genetics39(7)839-47(2007 Jul)
Peacock CS,Seeger K,Harris D,Murphy L,Ruiz JC,Quail MA,Peters N,Adlem E,Tivey A,Aslett M,Kerhornou A,Ivens A,Fraser A,Rajandream MA,Carver T,Norbertczak H,Chillingworth T,Hance Z,Jagels K,Moule S,Ormond D,Rutter S,Squares R,Whitehead S,Rabbinowitsch E,Arrowsmith C,White B,Thurston S,Bringaud F,Baldauf SL,Faulconbridge A,Jeffares D,Depledge DP,Oyola SO,Hilley JD,Brito LO,Tosi LR,Barrell B,Cruz AK,Mottram JC,Smith DF,Berriman M
-
-
Most Popular Services
-
Services & Products
-
News & Blogs
- Uncovering Nucleic Acid Payload and Size of Lipid Nanoparticles via a Single Nanoparticle Analyzer
- Severe Respiratory Infections: New Mechanism for Pathology
- Driving Antibody Development through Improved Engineering Technologies
- Borrow Nature’s Manufacturing Process for Complex Drug Production Using - Engineered Yeast
- EGFRvIII specific CAR-NK cells for Glioblastoma
- Finding the Best Tumor Antigen Peptides for Immunotherapy
- New Technology Paired with NGS, Paves the Way for Novel Therapeutic Antibodies
- Synthetic Biology: 2018 Achievements and 2019 Prospects
-
-
-
PubMed
-
